Neuro-navigation systems are surgical guidance tools that integrate preoperative and intraoperative medical images into a single virtual space to guide surgical instruments and procedures in real-time. Neuro-navigation systems offer precise localization of targets in neurosurgery by fusing preoperative images from magnetic resonance imaging (MRI) and computed tomography (CT) scans with physiological data such as the patient's anatomy during surgery. The neuro-navigation systems provide an interactive visualization of surgical instruments, anatomy, and other variables in the operating room, allowing surgeons to accurately reach deep-seated targets. The global Neuro-navigation Systems Market is estimated to be valued at US$ 2283 Mn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The rising adoption of image-guided neuro-navigation systems in neurosurgical procedures is one of the major trends driving market growth. For complex neurological procedures such as tumor resections, aneurysm repairs, and biopsies, neuro-navigation significantly improves surgical precision and safety. Neuro-navigation systems guide surgeons by tracking surgical tools and correlating their position and trajectory to the patient's preoperative imaging studies. The enhanced visualization and localization abilities allow for minimally invasive approaches that reduce procedural times, blood loss, postoperative complications and length of hospital stay. Increasing incidence of neurological disorders such as brain tumors, epilepsy, and chronic pain conditions has propelled the demand for precision neurosurgery performed with the help of navigation systems.

Segment Analysis

Neuro-navigation Systems Market comprises two key segments - electromagnetic neuro-navigation systems and optical/non-optical neuro-navigation systems. The electromagnetic neuro-navigation systems segment currently dominates the market owing to the accuracy and precision offered by these systems in mapping the brain and spine, and guiding surgical tools and instruments. This segment accounted for over 55% of the total market share in 2024 due to the wide adoption of electromagnetic navigation systems by neurosurgeons and hospitals worldwide for procedures such as tumor removal and epilepsy surgeries.

Key Takeaways

The Global Neuro-Navigation Systems Market Size is expected to witness high growth during the forecast period of 2023 to 2030.

Regional analysis: North America currently dominates the market and is expected to continue its dominance through 2030 due to the rising geriatric population, increasing healthcare expenditure, and growing adoption of technologically advanced neurosurgical navigation systems. Europe is the second largest regional market.

Key players operating in the Neuro-navigation Systems Market are Bayer AG, BASF SE, Syngenta AG (now owned by ChemChina), Corteva Agriscience, FMC Corporation, Nufarm Limited, Dow AgroSciences (part of Corteva Agriscience), UPL Limited, Adama Agricultural Solutions (part of Syngenta Group), AMVAC Chemical Corporation, Valent U.S.A. (part of Sumitomo Chemical), Isagro S.p.A. Bayer AG is one of the leading players in the market with its diverse product portfolio of electromagnetic and ultrasound-based neuro-navigation systems for brain and ENT surgeries.

Get More Insights Here

https://www.newsstatix.com/neuro-navigation-systems-market-size-share-growth-outlook-2023/